The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: A comparative study

Clinical Pharmacology and Therapeutics

Volumn 64, Issue 2, 1998, Pages 204-210

  Chompootaweep, Sumana ^a   Nunthapisud, Pongpun ^b   Trivijitsilp, Prasert ^b   Sentrakul, Prasertsri ^b   Dusitsin, Nikorn ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; URINE CULTURE; UROGENITAL TRACT DISEASE;

ASIA; BIOLOGY; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE METHODS--THERAPEUTIC USE; DEVELOPING COUNTRIES; DISEASES; ENDOCRINE SYSTEM; ESTROGENIC SUBSTANCES, CONJUGATED; ESTROGENS; FAMILY PLANNING; HORMONE REPLACEMENT THERAPY; HORMONES; MENOPAUSE; ORAL CONTRACEPTIVES, COMBINED--THERAPEUTIC USE; ORAL CONTRACEPTIVES--THERAPEUTIC USE; PHYSIOLOGY; REPRODUCTION; RESEARCH METHODOLOGY; RESEARCH REPORT; SIGNS AND SYMPTOMS--WOMEN; SOUTHEASTERN ASIA; STUDIES; THAILAND; TREATMENT; UROGENITAL EFFECTS--WOMEN; UROGENITAL SYSTEM; WOMEN;

ADMINISTRATION, INTRAVAGINAL; CONTRACEPTIVES, ORAL, COMBINED; ESTRADIOL; ESTROGENS, CONJUGATED (USP); FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; SEVERITY OF ILLNESS INDEX; THAILAND; WOMEN'S HEALTH;

EID: 0031669222     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90154-0     Document Type: Article

References (27)

1. McKinlay SM, Jeffreys M. The menopausal syndrome. Br J Prevent Soc Med 1974;28:108-15.
2. Brocklehurst JC, Fry J, Griffiths LL, Kalton G. Dysuria in old age. J Am Geriatr Soc 1971;19:582-90.
3. Yarnell JWG, St Leger AS. The prevalence, severity and factors associated with urinary incontinence in random sample of the elderly. Age Ageing 1979;8:81-5.
4. Iosif C, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257-60.
5. Molander U, Milsom I, Ekelund P, Mellstrom D. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas 1990;12:51-60.
6. Dusitsin N, Snidvongs W. The Thai experience. In: Berg G, Hammar M, editors. Proceedings of the Seventh International Congress on the Menopause, Stockholm, Sweden, 1993. New York: Parthenon Publishing; 1994.
7. Chompootweep S, Tankeyoon M, Yamarat K, Poomsuwan P, Dusitsin N. The menopausal age and climacteric complaints in Thai women in Bangkok. Maturitas 1993;17: 63-71.
8. Deutsch S, Ossowski R, Benjamin I. Comparison between degree of systemic absorption of vaginally and orally administered estrogens at different dose levels in postmenopausal women: communications in brief. Am J Obstet Gynecol 1981;139:967-8.
9. Coutinho EM, Mascarenhas I, de Acosta OM, Flores JG, Gu ZP, Ladipo OA, et al. Comparative study on the efficacy, acceptability, and side effects of a contraceptive pill administered by the oral and vaginal route: an international multicenter clinical trial. Clin Pharmacol Ther 1993;54:540-5.
10. Coutinho EM, de Souza JC, da Silva AR, de Acosta OM, Alvarez F, Brache V, et al. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial. Clin Pharmacol Ther 1993;53:65-75.
11. Whitehead MI, Minardi J, Ritchin Y, Sharpless. Systemic absorption of estrogen from Premarin vaginal cream. In: Cooke ID, editor. The role of estrogen/progestogen in the management of menopause. Lancaster: MTP Press; 1986. p. 63-70.
12. Martin PL, Greany MO, Burner AM, Brooks PM, Yen SS, Quigley ME. Estradiol, estrone and gonadotropin levels after use of vaginal estradiol. Obstet Gynecol 1984;63: 441-4.
13. Mattsson LA, Culberg G. A clinical evaluation of treatment with estriol cream versus suppository in postmenopausal women. Acta Obstet Gynecol Scand 1983;62:397-401.
14. Furuhjelm M, Karlgren E, Carlstrom K. Intravaginal administration of conjugated estrogens in premenopausal and postmenopausal women. Int J Gynecol Obstet 1980; 17:335-9.
15. Widhom O, Vartiainen E, Stenman UH, Wahlstrom T. The vaginal absorption of estriol and dienoestrol in postmenopausal women [abstract]. Arch Gynecol Suppl 1985; 237:152.
16. Nilsson K, Heimer G. Low dose oestradiol in the treatment of urogenital oestrogen deficiency: a pharmacokinetic and pharmacodynamic study. Maturitas 1992; 15:121-7.
17. Mattsson LA, Cullberg G, Eriksson O, Knutsson F. Vaginal administration of low-dose oestradiol: effects on the endometrium and vaginal cytology. Maturitas 1989;11: 217-22.
18. Brandberg A, Mellstrom D, Samside G. Low dose oral estriol treatment in elderly women with urogenital infection. Acta Obstet Gynecol Scand Suppl 1987;140:33-8.
19. Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989;27:251-6.
20. 2-generating lactobacilli. J Infect Dis 1991;164:94-100.
21. Stamey TA, Timothy M, Millar M, Mihara G. Recurrent urinary infections in adult women: the role of introital enterobacteria. Calif Med 1971;115:1-19.
22. Chan RC, Reid G, Irvin RT, Bruce AW, Costerton JW. Competitive exclusion of uropathogens from human uroepitehlial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 1985;47:84-9.
23. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. New Engl J Med 1993;329:753-6.
24. Wied GL, Davis ED. Comparative activity of progestational agents in the human endometrium and vaginal epithelium of surgical castrates. Ann NY Acad Sci 1958;71:599-616.
25. King RJB, Whithead MI, Campbell S, Minardi J. Effects of estrogen and progestin treatments on endometria from postmenopausal women. Cancer Res 1979;39:1094-101.
26. Dyer GI, Young O, Townsend PT, Collins WP, Whitehead MI. Dose-related changes in vaginal cytology after topical conjugated equine oestrogens. Br Med J 1982;284:789.
27. Carlstrom K, Karlgren E, Furuhjelm M, Ryd-Kjellen E. Effects of intravaginal oestrogen treatment upon the vaginal absorption of conjugated equine oestrogens. Maturitas 1982;4:277-83.